VNRX VOLITIONRX LTD
NYSE · SEC CIK 93314 · EDGAR
- Bought, last 12 months
- $136.7K 4 purchases by 3 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 400 since 2021-07-16, latest 2026-03-19
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Reynolds Cameron John | Pres, CEO, Dir | $63.1K | — |
| Innes Guy Archibald | Dir | $49.0K | — |
| STILL TIMOTHY I | Dir | $24.5K | — |
| Rubin Ethel | Dir | — | — |
| Retter Andrew | Chief Medical Off | — | — |
| Batchelor Ann-Louise | Group CMO | — | — |
| Henshall Mickie | Dir | — | — |
| Plummer Nicholas | GC - Volition Diagnostics | — | — |
| Nguyen Kim | Dir | — | — |
| Forterre Gael | Chief Commercial Off | — | — |
Transactions 379
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-04 | 2024-06-01 | VNRX | Retter Andrew | Chief Medical Off | A - Grant | $0.00 | +8,326 | 108.3K | +8% | $0 | |
| 2024-06-04 | 2024-06-01 | VNRX | Hughes Terig | CFO | A - Grant | $0.00 | +11.7K | 330.6K | +4% | $0 | |
| 2024-06-04 | 2024-06-01 | VNRX | Michel Gaetan | COO | A - Grant | $0.00 | +13.7K | 354.2K | +4% | $0 | |
| 2024-06-04 | 2024-06-01 | VNRX | Innes Guy Archibald | Dir | A - Grant | $0.00 | +16.0K | 651.7K | +3% | $0 | |
| 2024-06-04 | 2024-06-01 | VNRX | Plummer Nicholas | GC - Volition Diagnostics | A - Grant | $0.00 | +10.2K | 134.0K | +8% | $0 | |
| 2024-05-24 | 2024-05-23 | VNRX | Retter Andrew | Chief Medical Off | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 | |
| 2024-05-03 | 2024-05-01 | VNRX | Butera Salvatore Thomas | CEO, Volition Veterinary | F - Tax | $0.87 | -15.5K | 199.5K | -7% | -$13.5K | |
| 2024-01-26 | 2024-01-24 | VNRX | Batchelor Ann-Louise | Group CMO | A - Grant | $0.00 | +22.5K | 74.6K | +43% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +28.5K | 104.9K | +37% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Futcher Edward | Dir | A - Grant | $0.00 | +8,500 | 80.4K | +12% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Colman Alan | Dir | A - Grant | $0.00 | +8,500 | 186.8K | +5% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Forterre Gael | Chief Commercial Off | A - Grant | $0.00 | +25.9K | 128.2K | +25% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | A - Grant | $0.00 | +36.1K | 215.0K | +20% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Innes Guy Archibald | Dir | A - Grant | $0.00 | +8,500 | 635.7K | +1% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Rootsaert Rodney Gerard | Sec | A - Grant | $0.00 | +18.7K | 97.4K | +24% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Michel Gaetan | COO | A - Grant | $0.00 | +42.9K | 340.5K | +14% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Hughes Terig | CFO | A - Grant | $0.00 | +33.1K | 318.9K | +12% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Nguyen Kim | Dir | A - Grant | $0.00 | +8,500 | 45.7K | +23% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +50.1K | 1.75M | +3% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Faulkes Martin Charles | Executive Dir, Dir | A - Grant | $0.00 | +22.5K | 1.74M | +1% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Micallef Jacob Vincent | CSO | A - Grant | $0.00 | +23.4K | 258.5K | +10% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Henshall Mickie | Dir | A - Grant | $0.00 | +8,500 | 27.2K | +45% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Plummer Nicholas | GC - Volition Diagnostics | A - Grant | $0.00 | +29.3K | 123.7K | +31% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | Barnes Phillip | Dir | A - Grant | $0.00 | +8,500 | 33.2K | +34% | $0 | |
| I | 2024-01-03 | 2024-01-02 | VNRX | Eight Corp Ltd | 10% | S - Sale | $0.9 | -20.0K | 298.4K | -6% | -$18.0K |
| I | 2023-12-20 | 2023-12-15 | VNRX | Hever Investments Ltd | 10% | S - Sale | $0.75 | -20.0K | 318.4K | -6% | -$15.0K |
| 2023-12-19 | 2023-12-18 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $0.83 | +10.0K | 99.3K | +11% | +$8,300 | |
| 2023-12-18 | 2023-12-15 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $0.77 | +10.0K | 89.3K | +13% | +$7,700 | |
| 2023-12-14 | 2023-12-13 | VNRX | Rootsaert Rodney Gerard | Sec | P - Purchase | $0.6 | +10.0K | 78.7K | +15% | +$6,000 | |
| 2023-12-11 | 2023-12-08 | VNRX | Reynolds Cameron John | Pres, CEO, Dir | P - Purchase | $0.67 | +10.0K | 1.70M | +0.6% | +$6,700 | |
| 2023-11-28 | 2023-11-27 | VNRX | Innes Guy Archibald | Dir | P - Purchase | $0.77 | +20.0K | 627.2K | +3% | +$15.4K | |
| 2023-11-28 | 2023-11-27 | VNRX | Futcher Edward | Dir | P - Purchase | $0.8 | +9,000 | 71.9K | +14% | +$7,200 | |
| 2023-11-27 | 2023-11-24 | VNRX | Innes Guy Archibald | Dir | P - Purchase | $0.76 | +10.0K | 607.2K | +2% | +$7,600 | |
| 2023-11-24 | 2023-11-22 | VNRX | Innes Guy Archibald | Dir | P - Purchase | $0.71 | +20.0K | 597.2K | +3% | +$14.2K | |
| 2023-11-17 | 2023-11-16 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $0.81 | +10.0K | 79.3K | +14% | +$8,100 | |
| 2023-10-20 | 2023-10-19 | VNRX | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +200.0K | 1.69M | +13% | $0 | |
| 2023-10-20 | 2023-10-19 | VNRX | Hughes Terig | CFO | A - Grant | $0.00 | +100.0K | 285.7K | +54% | $0 | |
| 2023-10-20 | 2023-10-19 | VNRX | Faulkes Martin Charles | Executive Dir, Dir | A - Grant | $0.00 | +50.0K | 1.72M | +3% | $0 | |
| 2023-10-20 | 2023-10-19 | VNRX | Michel Gaetan | COO | A - Grant | $0.00 | +100.0K | 297.6K | +51% | $0 | |
| 2023-10-06 | 2023-10-04 | VNRX | Michel Gaetan | COO | F - Tax | $0.68 | -15.4K | 197.6K | -7% | -$10.5K | |
| 2023-10-06 | 2023-10-04 | VNRX | Forterre Gael | Chief Commercial Off | F - Tax | $0.68 | -5,527 | 102.3K | -5% | -$3,758 | |
| 2023-10-06 | 2023-10-04 | VNRX | Faulkes Martin Charles | Dir | F - Tax | $0.68 | -5,850 | 1.67M | -0.3% | -$3,978 | |
| 2023-10-06 | 2023-10-04 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | F - Tax | $0.68 | -5,834 | 178.9K | -3% | -$3,967 | |
| 2023-09-19 | 2023-08-31 | VNRX | Henshall Mickie | Dir | P - Purchase | $1.25 | +3,706 | 18.7K | +25% | +$4,632 | |
| 2023-09-06 | 2023-09-05 | VNRX | Barnes Phillip | Dir | P - Purchase | $1.30 | +5,000 | 24.7K | +25% | +$6,500 | |
| 2023-09-01 | 2023-08-31 | VNRX | Faulkes Martin Charles | Dir | P - Purchase | $1.28 | +9,716 | 1.67M | +0.6% | +$12.4K | |
| MI | 2023-08-31 | 2023-08-29+ | VNRX | Micallef Jacob Vincent | CSO | P - Purchase | $1.25 | +20.0K | 55.0K | +57% | +$25.1K |
| 2023-08-28 | 2023-08-25 | VNRX | Micallef Jacob Vincent | CSO | P - Purchase | $1.24 | +20.0K | 235.1K | +9% | +$24.8K | |
| I | 2023-08-25 | 2023-08-24 | VNRX | Kway Jasmine | CEO - Singapore Volition | P - Purchase | $1.20 | +5,000 | 10.4K | +93% | +$6,000 |
| 2023-08-25 | 2023-08-24 | VNRX | Futcher Edward | Dir | P - Purchase | $1.22 | +5,000 | 62.9K | +9% | +$6,100 | |
| 2023-08-24 | 2023-08-24 | VNRX | Michel Gaetan | COO | P - Purchase | $1.23 | +5,000 | 213.0K | +2% | +$6,150 | |
| 2023-08-17 | 2023-08-16 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $1.21 | +8,000 | 69.3K | +13% | +$9,680 | |
| 2023-08-16 | 2023-08-16 | VNRX | Reynolds Cameron John | Pres, CEO, Dir | P - Purchase | $1.22 | +10.0K | 1.49M | +0.7% | +$12.2K | |
| 2023-08-07 | 2023-08-03 | VNRX | Rootsaert Rodney Gerard | Sec | F - Tax | $1.30 | -4,850 | 68.7K | -7% | -$6,305 | |
| 2023-08-07 | 2023-08-03 | VNRX | Faulkes Martin Charles | Dir | F - Tax | $1.30 | -5,427 | 1.66M | -0.3% | -$7,055 | |
| 2023-08-07 | 2023-08-03 | VNRX | Micallef Jacob Vincent | CSO | F - Tax | $1.30 | -5,427 | 215.1K | -2% | -$7,055 | |
| 2023-08-07 | 2023-08-03 | VNRX | Batchelor Ann-Louise | Group CMO | F - Tax | $1.30 | -5,819 | 52.1K | -10% | -$7,565 | |
| 2023-08-07 | 2023-08-03 | VNRX | Forterre Gael | Chief Commercial Off | F - Tax | $1.30 | -3,597 | 107.8K | -3% | -$4,676 | |
| 2023-07-07 | 2023-07-05 | VNRX | Plummer Nicholas | GC - Volition Diagnostics | A - Grant | $0.00 | +23.4K | 94.4K | +33% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | A - Grant | $0.00 | +28.8K | 184.7K | +18% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +40.0K | 1.48M | +3% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | Nguyen Kim | Dir | A - Grant | $0.00 | +6,750 | 37.2K | +22% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | Colman Alan | Dir | A - Grant | $0.00 | +6,750 | 178.3K | +4% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | Barnes Phillip | Dir | A - Grant | $0.00 | +6,750 | 19.7K | +52% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | Futcher Edward | Dir | A - Grant | $0.00 | +6,750 | 57.9K | +13% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | Innes Guy Archibald | Dir | A - Grant | $0.00 | +6,750 | 577.2K | +1% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | Micallef Jacob Vincent | CSO | A - Grant | $0.00 | +17.6K | 220.6K | +9% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | Forterre Gael | Chief Commercial Off | A - Grant | $0.00 | +20.7K | 111.4K | +23% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | Batchelor Ann-Louise | Group CMO | A - Grant | $0.00 | +17.6K | 57.9K | +43% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | Rootsaert Rodney Gerard | Sec | A - Grant | $0.00 | +14.8K | 73.5K | +25% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | Hughes Terig | CFO | A - Grant | $0.00 | +24.8K | 185.7K | +15% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | Faulkes Martin Charles | Dir | A - Grant | $0.00 | +17.6K | 1.67M | +1% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | Michel Gaetan | COO | A - Grant | $0.00 | +33.3K | 208.0K | +19% | $0 | |
| 2023-07-07 | 2023-07-05 | VNRX | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +22.1K | 76.4K | +41% | $0 | |
| 2023-06-29 | 2023-06-27 | VNRX | Innes Guy Archibald | Dir | G - Gift | $0.00 | -1.00M | 570.4K | -64% | $0 | |
| I | 2023-06-29 | 2023-06-27 | VNRX | Innes Guy Archibald | Dir | G - Gift | $0.00 | +1.00M | 1.00M | New | $0 |
| 2023-06-06 | 2023-06-02 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $1.59 | +10.0K | 61.4K | +19% | +$15.9K | |
| 2023-05-03 | 2023-05-01 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | F - Tax | $1.67 | -14.3K | 155.9K | -8% | -$23.9K | |
| MI | 2023-02-23 | 2023-02-22 | VNRX | Innes Guy Archibald | Dir | P - Purchase | $1.75 | +234.0K | 154.5K | New | +$409.5K |
| 2023-01-13 | 2023-01-12 | VNRX | Nguyen Kim | Dir | A - Grant | $0.00 | +5,625 | 30.4K | +23% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Hughes Terig | CFO | A - Grant | $0.00 | +20.6K | 161.0K | +15% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Barnes Phillip | Dir | A - Grant | $0.00 | +5,625 | 12.9K | +77% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Colman Alan | Dir | A - Grant | $0.00 | +5,625 | 171.5K | +3% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Plummer Nicholas | GC - Volition Diagnostics | A - Grant | $0.00 | +19.5K | 71.0K | +38% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Faulkes Martin Charles | Dir | A - Grant | $0.00 | +14.6K | 1.65M | +0.9% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Futcher Edward | Dir | A - Grant | $0.00 | +5,625 | 51.2K | +12% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Rootsaert Rodney Gerard | Sec | A - Grant | $0.00 | +12.4K | 58.7K | +27% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +33.4K | 1.44M | +2% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Brudnick Richard | Dir | A - Grant | $0.00 | +5,625 | 27.9K | +25% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Kway Jasmine | CEO - Singapore Volition | A - Grant | $0.00 | +18.4K | 54.4K | +51% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Michel Gaetan | COO | A - Grant | $0.00 | +27.8K | 174.7K | +19% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Forterre Gael | Chief Commerical Off | A - Grant | $0.00 | +17.2K | 90.7K | +23% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Batchelor Ann-Louise | Group CMO | A - Grant | $0.00 | +14.6K | 40.4K | +57% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | A - Grant | $0.00 | +24.0K | 170.2K | +16% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Innes Guy Archibald | Dir | A - Grant | $0.00 | +5,625 | 1.57M | +0.4% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | Micallef Jacob Vincent | CSO | A - Grant | $0.00 | +14.6K | 203.0K | +8% | $0 | |
| M | 2022-12-20 | 2022-12-16+ | VNRX | Micallef Jacob Vincent | CSO | P - Purchase | $2.22 | +32.3K | 188.4K | +21% | +$71.9K |
| 2022-12-20 | 2022-12-19 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $2.27 | +5,000 | 51.4K | +11% | +$11.3K | |
| 2022-12-19 | 2022-12-16 | VNRX | Faulkes Martin Charles | Dir | P - Purchase | $2.10 | +55.0K | 1.64M | +3% | +$115.5K | |
| 2022-12-13 | 2022-12-12 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $2.09 | +4,350 | 46.4K | +10% | +$9,092 |
Purchase Sale Sale after option exercise All abbreviations